Navigation Links
Sequenom to Present at Two Financial Conferences in March
Date:3/3/2010

/PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that Harry F. Hixson, PhD, chairman and interim CEO, will present an overview of the company at the following conferences in March.

  • ROTH 22nd Annual OC Growth Stock Conference
  • Location: The Ritz Carlton, Dana Point, CA
  • Presentation Date: Wednesday March 17, 2010
  • Presentation time: 9:00am P.T.

  • Barclays Capital 2010 Global Healthcare Conference
  • Location: Loews Miami Hotel, Miami, FL
  • Presentation date: Wednesday, March 24, 2010
  • Presentation time: 2:00pm E.T.

A live webcast and 30-day archive of these presentations will be available at

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sequenom Appoints Two New Board Members
2. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
3. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
4. SEQUENOM Announces Launch of MassARRAY Compact 96 System
5. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
6. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
7. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
8. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
9. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
10. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... Aug. 26, 2015 /PRNewswire/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended June 30, ... Canadian dollars and presented under International Financial Reporting ... with respect to our Oral Amp B program, ... manufacturer," said Andrew Rae , President & ...
(Date:8/26/2015)... SAN FRANCISCO , Aug. 26, 2015 /PRNewswire/ ... today that it has received a $1.5M Phase ... Health (NIH) to further develop its therapeutic agent ... unmet clinical need in end stage renal disease ... by the National Institute of Diabetes and Digestive ...
(Date:8/26/2015)... 2015 After litigating and negotiating patent ... to P2i United States patent RE43,651 ... the United States without any admission ... either party. As a result of the parties, settlement, the ... California dismissed the case without prejudice. ...
(Date:8/25/2015)... --  WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), ... serving the pharmaceutical, biotechnology, and medical device industries, and ... Stock Code: 0950), a research-based biopharmaceutical company headquartered in ... of operations in China , today ... whereby WuXi,s Laboratory Testing Division (LTD) will be the ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3P2i Settles United States Litigation 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3
... Following the,completion of the Phase II clinical development of ... end of Phase,II meeting with the FDA to discuss ... there was an open and highly constructive discussion with ... the first ever formal discussions with the,agency to license ...
... developed at MIT and Boston University, could help prevent ... that have already become resistant. , Researchers from both ... defense systems, enhancing the effectiveness of antibiotics. The work ... the Proceedings of the National Academy of Sciences ...
... LAS VEGAS, March 2 American Pacific Corporation ... announce that its wholly-owned subsidiary AMPAC Fine Chemicals ... Award from the Department of Toxic Substances Control ... of California (CICC). The award recognizes the overall ...
Cached Biology Technology:Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting 2Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting 3MIT, BU team combats antibiotic resistance with engineered viruses 2AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years 2AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years 3
(Date:8/10/2015)... BOSTON and TELTOW, Germany ... SensoMotoric Instruments (SMI), a world leader in Eye ... the completion of its OEM Eye Tracking Platform for ... Eye Tracking Platform contains reference designs for seamless integration ... kiosk systems, virtual reality HMDs and augmented reality smart ...
(Date:8/6/2015)... JOSE, Calif. , Aug. 6, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... TouchPad technologies on Windows 10. Microsoft leveraged Synaptics, ... to the operating system. Through ... drivers are fully certified with Microsoft,s Precision TouchPad ...
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... not all the same when it comes to risk of ... researcher shows key differences among Hispanic populations that doctors should ... cardiovascular disease in this large and growing subset of the ... January 19, 2009 Journal of the American College of ...
... 15, 2009) -- In recent years, substantial advances ... understand the details of cellular structure and dynamics at ... edition of the popular laboratory manual Live Cell ... of established techniques--producing the most comprehensive and up-to-date source ...
... University Press has launched Illuminea, a new quarterly newsletter ... keep readers up-to-date with the latest developments at OUP ... Research Director for Journals at OUP, and member of ... with the library community we have developed a strong ...
Cached Biology News:Crucial differences found among Latino populations facing heart disease risks 2New edition of popular lab manual presents latest techniques for probing cellular dynamics 2
... The PRO S-7 stirrers deliver ... housing channels fluids away from ... features easy-to-use controls which allow ... 7"x7" ceramic tops feature a ...
... Agencourt AMPure is a ... that requires no sample transfer, ... efficiently purifies small and large ... or 384-well microplates. Agencourt AMPure ...
... These 1.5L PYREX trypsinizing ... homogenous tissue samples into cell ... proteins. Heavy beaded neck accepts ... enhance vigorous agitation. • Height ...
... The kit for stabilizing 50g of purified RNA ... Plus Kit delivers all of the advantages and ... in addition the RNA can be used for ... This product has been optimised for the stabilization ...
Biology Products: